000 01629 a2200409 4500
005 20250518080838.0
264 0 _c20200817
008 202008s 0 0 eng d
022 _a1532-2130
024 7 _a10.1016/j.ejpn.2019.12.024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPoisson, Kelsey
245 0 0 _aResponse to cannabidiol in epilepsy of infancy with migrating focal seizures associated with KCNT1 mutations: An open-label, prospective, interventional study.
_h[electronic resource]
260 _bEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
_cMar 2020
300 _a77-81 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAnticonvulsants
_xtherapeutic use
650 0 4 _aCannabidiol
_xtherapeutic use
650 0 4 _aChild, Preschool
650 0 4 _aEpileptic Syndromes
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aMutation
650 0 4 _aNerve Tissue Proteins
_xgenetics
650 0 4 _aPotassium Channels, Sodium-Activated
_xgenetics
650 0 4 _aProspective Studies
650 0 4 _aSeizures
_xdrug therapy
650 0 4 _aSpasms, Infantile
_xdrug therapy
700 1 _aWong, Matthew
700 1 _aLee, Chon
700 1 _aCilio, Maria Roberta
773 0 _tEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
_gvol. 25
_gp. 77-81
856 4 0 _uhttps://doi.org/10.1016/j.ejpn.2019.12.024
_zAvailable from publisher's website
999 _c30507907
_d30507907